Induced pluripotent stem cells for traumatic spinal cord injury

Frontiers in Cell and Developmental Biology

Volumn 4, Issue JAN, 2017, Pages

  Khazaei, Mohamad ^a   Ahuja, Christopher S ^a,b,c   Fehlings, Michael G ^a,b,c,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Induced pluripotent stem cell; IPS; Neural precursor cell; Spinal cord injury; Stem cell; Trauma

Indexed keywords

EID: 85018868464     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2016.00152     Document Type: Review

References (88)

1. Aasen, T., and Izpisúa Belmonte, J. C. (2010). Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Nat. Protoc. 5, 371-382. doi: 10.1038/nprot.2009.241
2. Aasen, T., Raya, A., Barrero, M. J., Garreta, E., Consiglio, A., Gonzalez, F., et al. (2008). Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 26, 1276-1284. doi: 10.1038/nbt.1503
3. Ahuja, C. S., and Fehlings, M. (2016). Concise review: bridging the gap: novel neuroregenerative and neuroprotective strategies in spinal cord injury. Stem Cells Transl. Med. 5, 914-924. doi: 10.5966/sctm.2015-0381
4. Ahuja, C. S., Martin, A. R., and Fehlings, M. (2016). Recent advances in managing a spinal cord injury secondary to trauma. F1000Res. 5:F1000 Faculty Rev-1017. doi: 10.12688/f1000research.7586.1
5. Araki, R., Uda, M., Hoki, Y., Sunayama, M., Nakamura, M., Ando, S., et al. (2013). Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature 494, 100-104. doi: 10.1038/nature11807
6. Badner, A., Vawda, R., Laliberte, A., Hong, J., Mikhail, M., Jose, A., et al. (2016). Early intravenous delivery of human brain stromal cells modulates systemic inflammation and leads to vasoprotection in traumatic spinal cord injury. Stem Cells Transl. Med. 5, 991-1003. doi: 10.5966/sctm.2015-0295
7. Ban, H., Nishishita, N., Fusaki, N., Tabata, T., Saeki, K., Shikamura, M., et al. (2011). Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc. Natl. Acad. Sci. U.S.A. 108, 14234-14239. doi: 10.1073/pnas.1103509108
8. Brockmann, F., Kramer, M., Bornhäuser, M., Ehninger, G., and Hölig, K. (2013). Efficacy and side effects of granulocyte collection in healthy donors. Transfus. Med. Hemother. 40, 258-264. doi: 10.1159/000354093
9. Bunnell, B. A., Flaat, M., Gagliardi, C., Patel, B., and Ripoll, C. (2008). Adipose-derived stem cells: isolation, expansion and differentiation. Methods 45, 115-120. doi: 10.1016/j.ymeth.2008.03.006
10. Chaddah, R., Arntfield, M., Runciman, S., Clarke, L., and van der Kooy, D. (2012). Clonal neural stem cells from human embryonic stem cell colonies. J. Neurosci. Off. J. Soc. Neurosci. 32, 7771-7781. doi: 10.1523/JNEUROSCI.3286-11.2012
11. Chambers, S. M., Mica, Y., Lee, G., Studer, L., and Tomishima, M. J. (2013). "Dual-SMAD inhibition/WNT activation-based methods to induce neural crest and derivatives from human pluripotent stem cells". in Human Embryonic Stem Cell Protocols, ed K. Turksen (New York, NY: Springer), 329-343. Available online at: http://link.springer.com/10.1007/7651_2013_59 (Accessed June 9, 2016)
12. Chen, J., Lin, M., Foxe, J. J., Pedrosa, E., Hrabovsky, A., Carroll, R., et al. (2013a). Transcriptome comparison of human neurons generated using induced pluripotent stem cells derived from dental pulp and skin fibroblasts. PLoS ONE 8:e75682. doi: 10.1371/journal.pone.0075682
13. Chen, J., Liu, H., Liu, J., Qi, J., Wei, B., Yang, J., et al. (2013b). H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat. Genet. 45, 34-42. doi: 10.1038/ng.2491
14. Chen, Y., McGee, J., Chen, X., Doman, T. N., Gong, X., Zhang, Y., et al. (2014). Identification of druggable cancer driver genes amplified across TCGA datasets. PLoS ONE 9:e98293. doi: 10.1371/journal.pone.0098293
15. Choo, A. M., Liu, J., Lam, C. K., Dvorak, M., Tetzlaff, W., and Oxland, T. R. (2007). Contusion, dislocation, and distraction: primary hemorrhage and membrane permeability in distinct mechanisms of spinal cord injury. J. Neurosurg. Spine 6, 255-266. doi: 10.3171/spi.2007.6.3.255
16. Colman, A., and Dreesen, O. (2009). Pluripotent stem cells and disease modeling. Cell Stem Cell 5, 244-247. doi: 10.1016/j.stem.2009.08.010
17. Davies, J. E., Huang, C., Proschel, C., Noble, M., Mayer-Proschel, M., and Davies, S. J. A. (2006). Astrocytes derived from glial-restricted precursors promote spinal cord repair. J. Biol. 5, 7. doi: 10.1186/jbiol35
18. Fandel, T. M., Trivedi, A., Nicholas, C. R., Zhang, H., Chen, J., Martinez, A. F., et al. (2016). Transplanted human stem cell-derived interneuron precursors mitigate mouse bladder dysfunction and central neuropathic pain after spinal cord injury. Cell Stem Cell 19, 544-557. doi: 10.1016/j.stem.2016.08.020
19. Faulkner, J. R., Herrmann, J. E., Woo, M. J., Tansey, K. E., Doan, N. B., and Sofroniew, M. V. (2004). Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. Off. J. Soc. Neurosci. 24, 2143-2155. doi: 10.1523/JNEUROSCI.3547-03.2004
20. Fujimoto, Y., Abematsu, M., Falk, A., Tsujimura, K., Sanosaka, T., Juliandi, B., et al. (2012). Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells. Stem Cells 30, 1163-1173. doi: 10.1002/stem.1083
21. Giorgetti, A., Montserrat, N., Aasen, T., Gonzalez, F., Rodríguez-Pizà, I., Vassena, R., et al. (2009). Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5, 353-357. doi: 10.1016/j.stem.2009.09.008
22. Gore, A., Li, Z., Fung, H.-L., Young, J. E., Agarwal, S., Antosiewicz-Bourget, J., et al. (2011). Somatic coding mutations in human induced pluripotent stem cells. Nature 471, 63-67. doi: 10.1038/nature09805
23. Guha, P., Morgan, J. W., Mostoslavsky, G., Rodrigues, N. P., and Boyd, A. S. (2013). Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell 12, 407-412. doi: 10.1016/j.stem.2013.01.006
24. Hallett, P. J., Deleidi, M., Astradsson, A., Smith, G. A., Cooper, O., Osborn, T. M., et al. (2015). Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's Disease. Cell Stem Cell 16, 269-274. doi: 10.1016/j.stem.2015.01.018
25. Han, D. W., Tapia, N., Hermann, A., Hemmer, K., Höing, S., Araúzo-Bravo, M. J., et al. (2012). Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell 10, 465-472. doi: 10.1016/j.stem.2012.02.021
26. Hayashi, K., Hashimoto, M., Koda, M., Naito, A. T., Murata, A., Okawa, A., et al. (2011). Increase of sensitivity to mechanical stimulus after transplantation of murine induced pluripotent stem cell-derived astrocytes in a rat spinal cord injury model. J. Neurosurg. Spine 15, 582-593. doi: 10.3171/2011.7.SPINE10775
27. Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., et al. (2008). Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol. 26, 795-797. doi: 10.1038/nbt1418
28. Jha, B. S., Rao, M., and Malik, N. (2015). Motor neuron differentiation from pluripotent stem cells and other intermediate proliferative precursors that can be discriminated by lineage specific reporters. Stem Cell Rev. 11, 194-204. doi: 10.1007/s12015-014-9541-0
29. Ji, J., Ng, S. H., Sharma, V., Neculai, D., Hussein, S., Sam, M., et al. (2012). Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells. Stem Cells 30, 435-440. doi: 10.1002/stem.1011
30. Kadoya, K., Lu, P., Nguyen, K., Lee-Kubli, C., Kumamaru, H., Yao, L., et al. (2016). Spinal cord reconstitution with homologous neural grafts enables robust corticospinal regeneration. Nat. Med. 22, 479-487. doi: 10.1038/nm.4066
31. Karumbayaram, S., Novitch, B. G., Patterson, M., Umbach, J. A., Richter, L., Lindgren, A., et al. (2009). Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 27, 806-811. doi: 10.1002/stem.31
32. Kim, D., Kim, C.-H., Moon, J.-I., Chung, Y.-G., Chang, M.-Y., Han, B.-S., et al. (2009). Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4, 472-476. doi: 10.1016/j.stem.2009.05.005
33. Kim, K., Zhao, R., Doi, A., Ng, K., Unternaehrer, J., Cahan, P., et al. (2011). Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat. Biotechnol. 29, 1117-1119. doi: 10.1038/nbt.2052
34. Kobayashi, Y., Okada, Y., Itakura, G., Iwai, H., Nishimura, S., Yasuda, A., et al. (2012). Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity. PLoS ONE 7:e52787. doi: 10.1371/journal.pone.0052787
35. LaPlaca, M. C., Simon, C. M., Prado, G. R., and Cullen, D. K. (2007). CNS injury biomechanics and experimental models. Prog. Brain Res. 161, 13-26. doi: 10.1016/S0079-6123(06)61002-9
36. Loh, Y.-H., Agarwal, S., Park, I.-H., Urbach, A., Huo, H., Heffner, G. C., et al. (2009). Generation of induced pluripotent stem cells from human blood. Blood 113, 5476-5479. doi: 10.1182/blood-2009-02-204800
37. Lujan, E., Chanda, S., Ahlenius, H., Südhof, T. C., and Wernig, M. (2012). Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. Proc. Natl. Acad. Sci. U.S.A. 109, 2527-2532. doi: 10.1073/pnas.1121003109
38. Maherali, N., Ahfeldt, T., Rigamonti, A., Utikal, J., Cowan, C., and Hochedlinger, K. (2008). A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3, 340-345. doi: 10.1016/j.stem.2008.08.003
39. Mautes, A. E. M., Weinzierl, M. R., Donovan, F., and Noble, L. J. (2000). Vascular events after spinal cord injury: contribution to secondary pathogenesis. Phys. Ther. 80, 673-687. doi: 10.1093/ptj/80.7.673
40. Meng, X., Neises, A., Su, R.-J., Payne, K. J., Ritter, L., Gridley, D. S., et al. (2012). Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 Alone. Mol. Ther. 20, 408-416. doi: 10.1038/mt.2011.258
41. Muratore, C. R., Srikanth, P., Callahan, D. G., and Young-Pearse, T. L. (2014). Comparison and optimization of hiPSC forebrain cortical differentiation protocols. PLoS ONE 9:e105807. doi: 10.1371/journal.pone.0105807
42. Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., et al. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26, 101-106. doi: 10.1038/nbt1374
43. National Spinal Cord Injury Statistical Center (2014). Spinal cord injury facts and figures at a glance. J. Spinal Cord Med. 37, 355-356. doi: 10.1179/1079026814Z.000000000260
44. Nicholas, C. R., Chen, J., Tang, Y., Southwell, D. G., Chalmers, N., Vogt, D., et al. (2013). Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development. Cell Stem Cell 12, 573-586. doi: 10.1016/j.stem.2013.04.005
45. Nori, S., Okada, Y., Yasuda, A., Tsuji, O., Takahashi, Y., Kobayashi, Y., et al. (2011). Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc. Natl. Acad. Sci. U.S.A. 108, 16825-16830. doi: 10.1073/pnas.1108077108
46. Nutt, S. E., Chang, E.-A., Suhr, S. T., Schlosser, L. O., Mondello, S. E., Moritz, C. T., et al. (2013). Caudalized human iPSC-derived neural progenitor cells produce neurons and glia but fail to restore function in an early chronic spinal cord injury model. Exp. Neurol. 248, 491-503. doi: 10.1016/j.expneurol.2013.07.010
47. Orlova, V. V., Drabsch, Y., Freund, C., Petrus-Reurer, S., van den Hil, F. E., Muenthaisong, S., et al. (2014). Functionality of endothelial cells and pericytes from human pluripotent stem cells demonstrated in cultured vascular plexus and zebrafish xenografts. Arterioscler. Thromb. Vasc. Biol. 34, 177-186. doi: 10.1161/ATVBAHA.113.302598
48. Park, I.-H., Lerou, P. H., Zhao, R., Huo, H., and Daley, G. Q. (2008). Generation of human-induced pluripotent stem cells. Nat. Protoc. 3, 1180-1186. doi: 10.1038/nprot.2008.92
49. Qu, X., Liu, T., Song, K., Li, X., and Ge, D. (2012). Induced pluripotent stem cells generated from human adipose-derived stem cells using a non-viral polycistronic plasmid in feeder-free conditions. PLoS ONE 7:e48161. doi: 10.1371/journal.pone.0048161
50. Quattrocelli, M., Palazzolo, G., Floris, G., Schöffski, P., Anastasia, L., Orlacchio, A., et al. (2011). Intrinsic cell memory reinforces myogenic commitment of pericyte-derived iPSCs. J. Pathol. 223, 593-603. doi: 10.1002/path.2845
51. Ramos-Mejía, V., Montes, R., Bueno, C., Ayllón, V., Real, P. J., Rodríguez, R., et al. (2012). Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors. PLoS ONE 7:e35824. doi: 10.1371/journal.pone.0035824
52. Red-Horse, K., Zhou, Y., Genbacev, O., Prakobphol, A., Foulk, R., McMaster, M., et al. (2004). Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J. Clin. Invest. 114, 744-754. doi: 10.1172/JCI200422991
53. Renault-Mihara, F., Okada, S., Shibata, S., Nakamura, M., Toyama, Y., and Okano, H. (2008). Spinal cord injury: emerging beneficial role of reactive astrocytes' migration. Int. J. Biochem. Cell Biol. 40, 1649-1653. doi: 10.1016/j.biocel.2008.03.009
54. Ring, K. L., Tong, L. M., Balestra, M. E., Javier, R., Andrews-Zwilling, Y., Li, G., et al. (2012). Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. Cell Stem Cell 11, 100-109. doi: 10.1016/j.stem.2012.05.018
55. Rowland, J. W., Lee, J. J., Salewski, R. P., Eftekharpour, E., van der Kooy, D., and Fehlings, M. G. (2011). Generation of neural stem cells from embryonic stem cells using the default mechanism: in vitro and in vivo characterization. Stem Cells Dev. 20, 1829-1845. doi: 10.1089/scd.2011.0214
56. Salewski, R. P., Buttigieg, J., Mitchell, R. A., van der Kooy, D., Nagy, A., and Fehlings, M. G. (2013). The generation of definitive neural stem cells from PiggyBac transposon-induced pluripotent stem cells can be enhanced by induction of the NOTCH signaling pathway. Stem Cells Dev. 22, 383-396. doi: 10.1089/scd.2012.0218
57. Salewski, R. P., Mitchell, R. A., Li, L., Shen, C., Milekovskaia, M., Nagy, A., et al. (2015). Transplantation of induced pluripotent stem cell-derived neural stem cells mediate functional recovery following thoracic spinal cord injury through remyelination of axons. Stem Cells Transl. Med. 4, 743-754. doi: 10.5966/sctm.2014-0236
58. Sareen, D., O'Rourke, J. G., Meera, P., Muhammad, A. K. M. G., Grant, S., Simpkinson, M., et al. (2013). Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci. Transl. Med. 5, 208ra149. doi: 10.1126/scitranslmed.3007529
59. Scheiner, Z. S., Talib, S., and Feigal, E. G. (2014). The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies. J. Biol. Chem. 289, 4571-4577. doi: 10.1074/jbc. R113.509588
60. Shi, Y., Kirwan, P., and Livesey, F. J. (2012a). Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks. Nat. Protoc. 7, 1836-1846. doi: 10.1038/nprot.2012.116
61. Shi, Y., Kirwan, P., Smith, J., Robinson, H. P. C., and Livesey, F. J. (2012b). Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat. Neurosci. 15, 477-486. doi: 10.1038/nn.3041
62. Sidney, L. E., Branch, M. J., Dunphy, S. E., Dua, H. S., and Hopkinson, A. (2014). Concise review: evidence for CD34 as a common marker for diverse progenitors. Stem Cells 32, 1380-1389. doi: 10.1002/stem.1661
63. Smukler, S. R., Runciman, S. B., Xu, S., and van der Kooy, D. (2006). Embryonic stem cells assume a primitive neural stem cell fate in the absence of extrinsic influences. J. Cell Biol. 172, 79-90. doi: 10.1083/jcb.200508085
64. Subramanyam, D., Lamouille, S., Judson, R. L., Liu, J. Y., Bucay, N., Derynck, R., et al. (2011). Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat. Biotechnol. 29, 443-448. doi: 10.1038/nbt.1862
65. Sun, N., Panetta, N. J., Gupta, D. M., Wilson, K. D., Lee, A., Jia, F., et al. (2009). Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc. Natl. Acad. Sci. U.S.A. 106, 15720-15725. doi: 10.1073/pnas.0908450106
66. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872. doi: 10.1016/j.cell.2007.11.019
67. Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. doi: 10.1016/j.cell.2006.07.024
68. Tetzlaff, W., Okon, E. B., Karimi-Abdolrezaee, S., Hill, C. E., Sparling, J. S., Plemel, J. R., et al. (2011). A systematic review of cellular transplantation therapies for spinal cord injury. J. Neurotrauma 28, 1611-1682. doi: 10.1089/neu.2009.1177
69. Tobias, C. A., Shumsky, J. S., Shibata, M., Tuszynski, M. H., Fischer, I., Tessler, A., et al. (2003). Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration. Exp. Neurol. 184, 97-113. doi: 10.1016/S0014-4886(03)00394-7
70. Tropepe, V., Hitoshi, S., Sirard, C., Mak, T. W., Rossant, J., and van der Kooy, D. (2001). Direct neural fate specification from embryonic stem cells: a primitive mammalian neural stem cell stage acquired through a default mechanism. Neuron 30, 65-78. doi: 10.1016/S0896-6273(01)00263-X
71. Tsuji, O., Miura, K., Okada, Y., Fujiyoshi, K., Mukaino, M., Nagoshi, N., et al. (2010). Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc. Natl. Acad. Sci. U.S.A. 107, 12704-12709. doi: 10.1073/pnas.0910106107
72. Ulndreaj, A., Chio, J. C. T., Ahuja, C. S., and Fehlings, M. G. (2016). Modulating the immune response in spinal cord injury. Expert Rev. Neurother. 16, 1127-1129. doi: 10.1080/14737175.2016.1207532
73. Utikal, J., Maherali, N., Kulalert, W., and Hochedlinger, K. (2009). Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J. Cell Sci. 122, 3502-3510. doi: 10.1242/jcs.054783
74. Vawda, R., Wilcox, J., and Fehlings, M. (2012). Current stem cell treatments for spinal cord injury. Indian J. Orthop. 46, 10-18. doi: 10.4103/0019-5413.91629
75. Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., et al. (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630. doi: 10.1016/j.stem.2010.08.012
76. Waxman, S. G. (1989). Demyelination in spinal cord injury. J. Neurol. Sci. 91, 1-14. doi: 10.1016/0022-510X(89)90072-5
77. Whetstone, W. D., Hsu, J.-Y. C., Eisenberg, M., Werb, Z., and Noble-Haeusslein, L. J. (2003). Blood-spinal cord barrier after spinal cord injury: relation to revascularization and wound healing. J. Neurosci. Res. 74, 227-239. doi: 10.1002/jnr.10759
78. Wilcox, J. T., Satkunendrarajah, K., Zuccato, J. A., Nassiri, F., and Fehlings, M. G. (2014). Neural precursor cell transplantation enhances functional recovery and reduces astrogliosis in bilateral compressive/contusive cervical spinal cord injury. Stem Cells Transl. Med. 3, 1148-1159. doi: 10.5966/sctm.2014-0029
79. Woltjen, K., Michael, I. P., Mohseni, P., Desai, R., Mileikovsky, M., Hämäläinen, R., et al. (2009). piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458, 766-770. doi: 10.1038/nature07863
80. Wu, C., Hong, S. G., Winkler, T., Spencer, D. M., Jares, A., Ichwan, B., et al. (2014). Development of an inducible caspase-9 safety switch for pluripotent stem cell-based therapies. Mol. Ther. Methods Clin. Dev. 1:14053. doi: 10.1038/mtm.2014.53
81. Yamanaka, S. (2009). Elite and stochastic models for induced pluripotent stem cell generation. Nature 460, 49-52. doi: 10.1038/nature08180
82. Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., et al. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797-801. doi: 10.1126/science.1172482
83. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920. doi: 10.1126/science.1151526
84. Zhang, Y., Pak, C., Han, Y., Ahlenius, H., Zhang, Z., Chanda, S., et al. (2013). Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78, 785-798. doi: 10.1016/j.neuron.2013.05.029
85. Zhao, T., Zhang, Z.-N., Rong, Z., and Xu, Y. (2011). Immunogenicity of induced pluripotent stem cells. Nature 474, 212-215. doi: 10.1038/nature10135
86. Zhao, Y., Yin, X., Qin, H., Zhu, F., Liu, H., Yang, W., et al. (2008). Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 3, 475-479. doi: 10.1016/j.stem.2008.10.002
87. Zhou, W., and Freed, C. R. (2009). Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 27, 2667-2674. doi: 10.1002/stem.201
88. Zou, Q., Yan, Q., Zhong, J., Wang, K., Sun, H., Yi, X., et al. (2014). Direct conversion of human fibroblasts into neuronal restricted progenitors. J. Biol. Chem. 289, 5250-5260. doi: 10.1074/jbc. M113.516112